Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The global multivitamin market size was $1.63 billion in 2022 and is expected to surpass $2.72B–expanding at a CAGR of 5.9% by the end of 2031, according to a study by Growth Market Reports.
read more
Apex Labs announced Health Canada approval of the company's secondary US-based supplier of good manufacturing practices (GMP) psilocybin active pharmaceutical ingredient (API) in addition to its existing primary Canadian-based supplier.
read more
The lactobacillus acidophilus probiotics market was worth $2.60B in 2022 and is projected to reach $5.25B by 2031, expanding at a CAGR of 8.1% during the forecast period, according to a report by Growth Market Reports.
read more
The global amino acid in dietary supplements market was valued at $25.1B in 2022 and is expected to expand to $65.5B by 2030, at a CAGR of 11.10% during the forecast period 2023-2030, according to a report by Research & Markets.
read more
The global pea protein market is projected to reach $4.7B by 2030, expanding at 12.0% CAGR from 2023 to 2030, according to a report by Grand View Research.
read more
Wilson Tool International, who manufacturers punch and die components in the tableting industry (among others) announced Paul Johnson as new chief executive officer. He will replace Brian Robinson, who will be retiring in the fall of 2023.
read more
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of an investigational single tablet combination therapy of macitentan 10mg and tadalafil 40mg (M/T STCT) for the long-term treatment of pulmonary arterial hypertension (...
read more
Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services, opening its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, ...
read more
The Europe spirulina market is expected to reach $156.61M by 2030, at a CAGR of 13.3% from 2023 to 2030, while in terms of volume, the market is expected to reach 8,308.8 tons by 2030, at a CAGR of 7.5% from 2023 to 2030, according to a report from Research & Markets.
read more
The U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is the fourth drug—and first oral antiviral ...
read more
The sustained release coating market for drugs will see incremental growth of $207.64M from 2022-2027, at a CAGR of 6.11%, according to a report by Technavio.
read more
Upsher-Smith announced the launch of Dicyclomine Hydrochloride Capsules, USP 10 mg. The company now offers the product in tablet and capsule forms.
read more
Roquette, a pharmaceutical and nutraceutical excipients manufacturer, announced the launch of PEARLITOL® ProTec, a plant-based co-processed blend of mannitol and maize starch.
read more
The U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of adults with moderately to severely active Crohn's disease who have had an inadequate response or intolerance to one or more TNF blockers.
read more
The global mannitol market was valued at $390.83M in 2022, estimated to reach $575.20M by 2030, with a CAGR of 4.81% from 2023-2030.
read more